Acadia Healthcare(ACHC)
Search documents
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
Zacks Investment Research· 2024-01-08 16:23
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Acadia Healthcare (ACHC) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Acadia Healthcare is one of 1077 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector ...
Acadia Healthcare (ACHC) is a Top-Ranked Value Stock: Should You Buy?
Zacks Investment Research· 2024-01-04 16:19
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores. ...
Acadia Healthcare to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Businesswire· 2024-01-03 16:00
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference, January 8-11, 2024, at The Westin St. Francis, San Francisco, California. In connection with the conference, there will be a webcast of the Company’s presentation available on the Company’s website starting at 2:15 p.m. Pacific Time/4:15 p.m. Central Time on Tuesday, January 9, 2024. The live webcast of the presentation will be ...
Acadia Healthcare(ACHC) - 2023 Q3 - Earnings Call Transcript
2023-11-03 17:18
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Q3 2023 Earnings Conference Call November 3, 2023 9:00 AM ET Company Participants Gretchen Hommrich - Vice President-Investor Relations Chris Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners A.J. Rice - Credit Suisse Kevin Fishbeck - Bank of America Ben Hendrix - RBC Brian Tanquilut - Jefferies John Ransom - Raymond James Sarah James - Cantor Fitzgerald Gary Taylor - Cowen Pito Chi ...
Acadia Healthcare(ACHC) - 2023 Q3 - Quarterly Report
2023-11-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-35331 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Dela ...
Acadia Healthcare(ACHC) - 2023 Q2 - Earnings Call Transcript
2023-07-28 18:05
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Q2 2023 Earnings Conference Call July 28, 2023 9:30 AM ET Company Participants Gretchen Hommrich – Vice President-Investor Relations Chris Hunter – Chief Executive Officer Heather Dixon – Chief Financial Officer Conference Call Participants Andrew Mok – UBS Whit Mayo – Leerink Partners A.J. Rice – Credit Suisse John Ransom – Raymond James Gary Taylor – Cowen Pito Chickering – Deutsche Bank John Ransom – Raymond James Brian Tanquilut – Jefferies Operator Good day ...
Acadia Healthcare(ACHC) - 2023 Q2 - Quarterly Report
2023-07-27 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-35331 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware ...
Acadia Healthcare(ACHC) - 2023 Q1 - Earnings Call Transcript
2023-04-27 19:13
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Q1 2023 Results Conference Call April 27, 2023 9:00 AM ET Company Participants Gretchen Hommrich - VP, IR Chris Hunter - CEO David Duckworth - CFO Conference Call Participants Whit Mayo - SVB Securities Andrew Mok - UBS Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse John Ransom - Raymond James Brian Tanquilut - Jefferies Pito Chickering - Deutsche Bank Gary Taylor - Cowen Operator Good morning. And welcome to Acadia Healthcare's First Quarter 2023 E ...
Acadia Healthcare(ACHC) - 2023 Q1 - Quarterly Report
2023-04-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-35331 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Delaware ...
Acadia Healthcare Company (ACHC) Presents at the 44th Annual Raymond James Institutional Investors Conference - Slideshow
2023-03-10 13:48
Raymond James Institutional Investors Conference Orlando, FL | March 7, 2023 Safe Harbor Some of the statements made in this presentation constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include any statements that address future results or occurrences. In some cases, you can identify forward-looking statements by terminology such as “may,” “might”, “will”, “should,” “could” or the negative thereof. Generally, the ...